BioXcel Therapeutics, Inc.

BTAINASDAQ Capital Market·USD·Closed

BTAINASDAQ·USD·Closed

$1.24

+6.47%

$1.24

+$0.07 (6.47%)

52W Range

3thpctl

Volume

0.32×avg

Mkt Cap

38.13MUSD

P/E

-0.2TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

3thpctl

Volume

0.32×avg

Market Cap

38.13MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-71.7% / yr

Operating margin-7395.0%

ROIC-3439.5%

Financially safe

Stretched

Debt / equity-0.95×

Interest coverage-2.9×

Current ratio0.62×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required